Minerva Neurosciences, Inc.
NERV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001598646
No open-market purchases or sales by Minerva Neurosciences, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $234.8M in total; no superinvestor holds it.
Holders of 5% or more of NERV
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Minerva Neurosciences, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Federated Hermes, Inc. | 13G | 19.86%9.39M shares | New | Dec 29, 20251 filing | Dec 29, 2025 | SEC |
| Vivo Opportunity Fund Holdings, L.P. | 13G | 9.99%8.59M shares | New | Dec 31, 20251 filing | Dec 31, 2025 | SEC |
| Farallon Capital Partners, L.P. | 13G | 9.99%4.54M shares | New | Dec 29, 20251 filing | Dec 29, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Minerva Neurosciences, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Dec 31, 20254:30 PM ET | Vivo Opportunity Fund Holdings, L.P.and 3 others | 13G | 9.99%8.59M shares | New | Dec 23, 2025 | SEC |
| Dec 30, 20254:05 PM ET | Boehringer AGand 1 other | 13D/A | 3.40%1.50M shares | –Below 5% | Dec 23, 2025 | SEC |
| Dec 29, 20254:05 PM ET | Farallon Capital Partners, L.P.and 27 others | 13G | 9.99%4.54M shares | New | Dec 22, 2025 | SEC |
| Dec 29, 20258:29 AM ET | Federated Hermes, Inc.and 4 others | 13G | 19.86%9.39M shares | New | Dec 22, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Minerva Neurosciences, Inc. shares.
No Form 144 notices for Minerva Neurosciences, Inc. are on file.